Lymphastat F
NDC 44911-0706, Echinacea (Angustifolia), Tabebuia Impetiginosa, Abies Nigra, Borax, Lycopodium Clavatum, Nux Vomica, Phosphorus, Pulsatilla (Vulgaris), Sepia, Thuja Occidentalis, Skatolum, Candida Albicans, liquid, from Energique, Inc.
- Product NDC
- 44911-0706
- Status
- Listed
- Labeler
- Energique, Inc
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/44911-0706 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ECHINACEA ANGUSTIFOLIA WHOLE3 [hp_X]/mL
- HANDROANTHUS IMPETIGINOSUS BARK3 [hp_X]/mL
- PICEA MARIANA RESIN12 [hp_X]/mL
- SODIUM BORATE12 [hp_X]/mL
- LYCOPODIUM CLAVATUM SPORE12 [hp_X]/mL
- STRYCHNOS NUX-VOMICA SEED12 [hp_X]/mL
- PHOSPHORUS12 [hp_X]/mL
- PULSATILLA VULGARIS WHOLE12 [hp_X]/mL
- SEPIA OFFICINALIS JUICE12 [hp_X]/mL
- THUJA OCCIDENTALIS LEAFY TWIG12 [hp_X]/mL
- SKATOLE15 [hp_X]/mL
- CANDIDA ALBICANS30 [hp_X]/mL
Pharmacologic classes
Allergens [CS]; Allergens [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Plant Allergenic Extract [EPC]; Plant Proteins [CS]; Seed Storage Proteins [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 44911-0706-1 | 44911070601 | 30 mL in 1 BOTTLE, DROPPER (44911-0706-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 44911-0706 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/44911-0706 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 44911-0706. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.